Biosimilars 301: Biosimilars in Canada Today: Payer, Policy, Patients and the Pharmacist Role (Pear Health)

Summary

This course reviews the current landscape of biologics and biosimilars in Canada, as well as Health Canada’s guidance on the use of biosimilars in practice.
Pharmacists will learn about clinical considerations for the use of biosimilars through practical scenarios, as well as recommendations for minimizing the nocebo effect and for monitoring outcomes in patients using biologics.